Skip to main content

Sodium Sulfacetamide 9% - Sulfur 4%

Generic: SULFACETAMIDE SODIUM, SULFUR

Unverified·never
Manufacturer
PruGen
RxCUI
1001714
Route
TOPICAL
ICD-10 indication
L70.0

Affordability Check

How much will you actually pay for Sodium Sulfacetamide 9% - Sulfur 4%?

In 30 seconds, see every legitimate way to afford Sodium Sulfacetamide 9% - Sulfur 4% — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Sodium Sulfacetamide 9% - Sulfur 4%

What is this medication? Sodium Sulfacetamide 9% - Sulfur 4% is a prescription topical treatment used to manage several common skin conditions, including acne vulgaris, rosacea, and seborrheic dermatitis. This combination medication is designed to reduce skin inflammation and clear up various types of skin lesions. It is typically available as a wash, lotion, or cream and is applied directly to the affected skin areas to help control symptoms and improve the overall appearance of the skin.

The medication works through the dual action of its two primary components. Sodium sulfacetamide is an antibacterial agent that stops the growth of bacteria on the skin and provides anti-inflammatory benefits to calm redness. Sulfur serves as a keratolytic agent that helps to break down dead skin cells and clear blocked pores. By combining these two ingredients, the medication effectively targets bacterial growth, excess oil, and clogged pores to treat active flare-ups and prevent future breakouts.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Sodium Sulfacetamide 9% - Sulfur 4%. Official source: DailyMed (NLM) · Label effective Jan 12, 2026

Indications and usage
INDICATIONS: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Dosage and administration
DOSAGE AND ADMINISTRATION: Cleanse affected areas. Apply a thin layer to the affected areas with light massaging, 1 to 3 times daily or as directed by a physician.
Contraindications
CONTRAINDICATIONS: This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. This product is not to be used by patients with kidney disease.
Warnings
WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF THE REACH OF CHILDREN.
Adverse reactions
ADVERSE REACTIONS: Reports of irritation and hypersensitivity to sodium sulfacetamide are uncommon. The following adverse reactions, reported after administration of sterile ophthalmic sodium sulfacetamide, are noteworthy: instances of Stevens-Johnson syndrome and instances of local hypersensitivity which progressed to a syndrome resembling systemic lupus erythematosus; in one case a fatal outcome was reported (see WARNINGS).

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.